- Companies
- Ulab Systems
Ulab Systems Funding, Investors & Competitors
Ulab Systems has raised $194M across 6 funding rounds, most recently a $91M undisclosed-stage round in September 2022.
Last Ulab Systems funding round
$91M
Undisclosed stage · Sep 2022
Cumulative funding Ulab Systems raised
$194M
across 6 funding rounds
Key investors in Ulab Systems
Civilization Ventures
Park West Asset Management
7 Gate Ventures
Light Bridge Ventures
CareCapital
DM Capital
Iratel Ventures
PineCypress Fund
About Ulab Systems
Ulab Systems is a digital dental treatment planning software developer with breakthrough technology. ULab's proprietary architecture and fully automated features enable orthodontists to create chairside treatment plans in less than five minutes for the first time.
Founded
2015
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Subscription
Ulab Systems Funding History
Ulab Systems has raised a total of $194M across 6 funding rounds.
Ulab Systems' first fundraising round was a $5M seed round in September 2017. The most recent completed round was a $91M undisclosed-stage round in September 2022.
Ulab Systems funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| Sep 2022 | Undisclosed stage | - | $91M | uLab Systems is the creator of uDesign® treatment planning software and uSmile™ clear aligners, serving orthodontists with an integrated digital treatment platform. The company completed a $20 million convertible note financing from CareCapital in March 2022, which the company used to advance distribution and development of its platform featuring AI-assisted treatment planning, rapid US-based aligner manufacturing, and the ability to plan for both brackets and aligners in the same case. Prior to this, uLab raised $54.5 million in an oversubscribed Series E financing round in July 2021 with participation from existing investors and a syndicate of leading orthodontia investors. By March 2022, uLab had achieved over 400,000 aligner and retainer cases planned across North America. An independent source estimated uLab's annual revenue at $54.3 million (as of an unspecified recent date), with approximately 173 employees and a total funding amount of $83.4 million. |
| Mar 2022 | Undisclosed stage | CareCapital (lead); PineCypress Fund | $20M | uLab Systems is a US-based medical technology company developing digital orthodontic solutions, including the uDesign AI-assisted treatment planning software and uSmile clear aligners, aimed at orthodontists for chairside planning, hybrid treatments combining brackets and aligners, and US-manufactured rapid delivery with custom packaging. On March 3, 2022, the company raised $20 million in a convertible note financing from CareCapital, a dental-focused equity investor, with no mention of PineCypress Fund involvement in this specific round. The funds are designated for expanding distribution and development of its orthodontic platform. By the time of the financing, uLab had achieved significant traction with over 400,000 aligner and retainer cases planned in North America. CareCapital highlighted uLab's orthodontist-centric approach, innovation in treatment control, lab fee management, and practice branding support. Company executives, including co-founder and CTO Charlie Wen, emphasized CareCapital's expertise in digital dental technologies. This round follows prior financings, including an $18 million Series D in January 2020 led by Park West Asset Management, a $54.5 million oversubscribed Series E in July 2021, and precedes a Series E-II for $36.44 million in September 2022. |
| Apr 2021 | Series E | Light Bridge Ventures; 7 Gate Ventures; Civilization Ventures; Park West Asset Management | $55M | uLab Systems is a dental technology company that creates uSmile Clear Aligners and offers an AI-assisted treatment planning platform for orthodontists. The company developed a breakthrough platform featuring efficient AI-assisted treatment planning, innovative pricing, rapid aligner delivery, the ability to plan for both brackets and aligners in the same case, and customized packaging. By the time of its Series E funding round, uLab had planned more than 250,000 aligner cases in the U.S. and had recently launched its treatment planning and aligner delivery system in Canada. On July 6, 2021, uLab Systems closed a Series E financing round of $54.5 million in an oversubscribed offering that included participation from existing investors and a new syndicate of leading orthodontists. According to company leadership, the funding would accelerate commercial expansion and enable uLab to position itself as a formidable competitor in the clear aligner market. The company stated that orthodontists recognized uLab as the source of innovation and pricing leadership in the market, motivating them to invest alongside institutional investors. The capital would support further advancement of uLab's commercial rollout and platform development, including continued expansion to additional international markets beyond Canada. |
| Jan 2020 | Series D | Park West Asset Management (lead) | $18M | uLab Systems, founded in 2015 and based in Redwood City, California, develops state-of-the-art aligner planning software called uDesign and uSmile clear aligners, empowering orthodontists with AI-assisted treatment planning, rapid US-based manufacturing, and hybrid bracket-aligner options. The company completed an $18 million Series D financing round on January 27, 2020, led by Park West Asset Management with support from minority investors including Ortho Studio Express, to advance its platform and return treatment control to orthodontists. Park West Portfolio Manager Tony Bartsh praised the software's efficiency, noting orthodontists can create plans in as little as 10 minutes, while uLab President and CTO Charlie Wen highlighted the partnership's role in industry innovation. By early 2020, uLab had significant traction with over 400,000 aligner and retainer cases scheduled in North America, demonstrating strong adoption among orthodontic practices. The platform's features include chairside planning, customizable pricing, and orthodontist-centric branding, positioning uLab against larger players in the clear aligner market by emphasizing speed, control, and cost management. Following the Series D, uLab continued fundraising with a $54.5 million oversubscribed Series E in July 2021 from existing and new investors, and a $20 million convertible note from CareCapital in March 2022, alongside a later Series E-II of $36.44 million in September 2022, bringing total funding to approximately $134.96 million across multiple rounds. Investors include CareCapital, State of Tennessee, Ortho Studio Express, and 3M Ventures, reflecting sustained interest in uLab's digital orthodontic solutions. |
| Mar 2019 | Series C | Light Bridge Ventures (lead) | $6M | uLab Systems completed a $6 million Series C financing round led by Light Bridge Ventures, with the announcement made on January 23, 2019. The company develops chairside aligner treatment planning software that enables dental practitioners to create treatment plans in approximately 10 minutes. At the time of the Series C round, uLab Systems was in the final stages of a pilot launch with a planned full commercial release at the American Association of Orthodontists' annual meeting in May 2019. During the pilot phase, the company had completed movement plans for over 6,000 aligner cases in approximately six months, demonstrating significant adoption among participating orthodontists. The capital was intended to support the company's full commercial launch and growth strategy, with Light Bridge Ventures providing both growth capital and strategic ties to the Asian marketplace. The company also indicated plans to complete development of its uContour system for automated aligner trimming. |
| Sep 2017 | Seed | 7 Gate Ventures; Iratel Ventures; Civilization Ventures; DM Capital | $5M | - |
Who has invested in Ulab Systems?
8 investors have backed Ulab Systems across its funding rounds, including Civilization Ventures, Park West Asset Management, 7 Gate Ventures, Light Bridge Ventures, CareCapital and DM Capital.
Lead investors include CareCapital, Park West Asset Management and Light Bridge Ventures.
Ulab Systems Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 2 | Lead | Mar 2019 | ||
| 2 | Participant | Sep 2017 | ||
| 2 | Participant | Sep 2017 | ||
| 2 | Lead | Jan 2020 | ||
| 1 | Participant | Mar 2022 | ||
| 1 | Participant | Sep 2017 | ||
This data is available for Pro users. Sign up to see all 8 Ulab Systems investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialUlab Systems Competitors
Ulab Systems competitors include listed companies like IQVIA, Veeva, IDEXX Laboratories and Roper Technologies, and private ones like Commure and Doctolib.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Publicly listed | $16B | $3.4B | $44B | 3.4x | ||
| Publicly listed | $3.2B | $965M | $43B | 10.2x | ||
| Publicly listed | $4.3B | $1.5B | $40B | 8.9x | ||
| Publicly listed | $7.9B | $3.2B | $37B | 5.7x | ||
| Private | $200M | - | $7B | 35.0x | ||
| Private | $400M | - | $6.4B | 16.0x |
Ulab Systems Public Comps
Ulab Systems is still privately-owned, but its public comps include IQVIA, Veeva, IDEXX Laboratories, Roper Technologies, GE HealthCare, ICON plc, Pro Medicus, United Imaging, Glaukos and M3 Inc..
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $16B | $3.4B | 3.6x | 3.4x | 17.2x | 14.8x | |||
| $3.2B | $965M | 11.1x | 10.2x | 36.9x | 22.4x | |||
| $4.3B | $1.5B | 9.5x | 8.9x | 27.1x | 24.9x | |||
| $7.9B | $3.2B | 6.1x | 5.7x | 15.2x | 14.6x | |||
| $21B | $3.7B | 1.8x | 1.8x | 10.1x | 10.0x | |||
| $8.3B | $816M | 1.9x | 1.9x | 19.2x | 11.3x | |||
| $186M | $147M | 66.6x | 62.7x | 84.4x | 77.6x | |||
| $2.1B | $367M | 5.5x | 4.8x | 30.7x | 26.9x | |||
This data is available for Pro users. Sign up to see all Ulab Systems competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Ulab Systems
| When was Ulab Systems founded? | Ulab Systems was founded in 2015. |
| Where is Ulab Systems headquartered? | Ulab Systems is headquartered in Memphis, TN, United States. |
| Is Ulab Systems publicly listed? | No, Ulab Systems is a private, VC-backed company. |
| How much funding has Ulab Systems raised? | Ulab Systems has raised $194M across 6 funding rounds. |
| What was Ulab Systems' last funding round? | Ulab Systems' last funding round was a $91M undisclosed-stage round in September 2022. |
| Who are Ulab Systems' investors? | Ulab Systems' investors include Light Bridge Ventures, 7 Gate Ventures, Civilization Ventures, Park West Asset Management, PineCypress Fund, Iratel Ventures, CareCapital and DM Capital. |
| Which companies are comparable to Ulab Systems? | Companies comparable to Ulab Systems include IQVIA, Veeva, IDEXX Laboratories, Roper Technologies, Commure and Doctolib. |
See companies similar to Ulab Systems
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




